NR3C2 and bacterial urinary tract infection: When purified recombinant MrpA (the main structural subunit of MR/P) was tested as a vaccine antigen in an ascending and a hematogenous model of UTI in mice, the subcutaneously immunized animals appeared to be protected against P. mirabilis UTI (Pellegrino et al., 2003).